Literature DB >> 9778334

Development of endothelium-dependent relaxation in canine coronary collateral arteries.

J A Rapps1, P R Myers, Q Zhong, J L Parker.   

Abstract

BACKGROUND: Little information exists regarding development of vasomotor control mechanisms during coronary collateral artery maturation. Therefore, we studied endothelium-dependent relaxation of canine collateral arteries isolated 2, 4, and 9 months after placement of an ameroid occluder around the proximal left circumflex coronary artery.
RESULTS: Collateral arteries isolated after 2 months exhibited markedly reduced endothelium-dependent relaxation in response to acetylcholine (ACh; 10(-10) to 10(-4) mol/L) and bradykinin (BK; 10(-11) to 10(-6) mol/L) compared with relaxation of noncollateral coronary arteries (P<0.01). In contrast, endothelium-independent relaxation of collateral arteries to nitroprusside was only slightly reduced compared with relaxation of noncollateral arteries (P<0.05). Endothelium-dependent relaxation of collateral arteries isolated after 4 and 9 months was increased significantly, to the extent that relaxation to ACh and BK was not significantly different between collateral and noncollateral arteries at these periods. Inhibition of nitric oxide synthesis with NT-nitro-L-arginine methyl ester (L-NAME; 100 micromol/L) markedly inhibited ACh-induced relaxation in all noncollateral arteries and in collateral arteries isolated after 9 months. However, neither L-NAME nor indomethacin (5 micromol/L) alone inhibited ACh-mediated relaxation of collateral arteries isolated after 4 months. ACh-induced relaxation of these collateral arteries was only inhibited when arteries were preconstricted with 30 mmol/L K+ and pretreated with L-NAME and indomethacin (ie, when synthesis/effects of nitric oxide, prostaglandins, and endothelium-derived hyperpolarizing factor were inhibited).
CONCLUSIONS: Development of endothelium-dependent relaxation in canine coronary collateral arteries is not complete after 2 months. After 4 months, endothelium-dependent relaxation of collateral arteries is similar to relaxation of noncollateral arteries, but the relaxation exhibits decreased dependence on synthesis of nitric oxide and increased involvement of prostaglandins and endothelium-derived hyperpolarizing factor(s). After 9 months of development, collateral arteries exhibit normal nitric oxide-dependent relaxation, similar to noncollateral arteries.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778334     DOI: 10.1161/01.cir.98.16.1675

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  The role of collateral circulation in preserving myocardial function.

Authors:  Aida Hasanović; Amela Kulenović; Fuad Sisić
Journal:  Bosn J Basic Med Sci       Date:  2006-11       Impact factor: 3.363

Review 2.  Effects of exercise training on coronary collateralization and control of collateral resistance.

Authors:  Cristine L Heaps; Janet L Parker
Journal:  J Appl Physiol (1985)       Date:  2011-05-12

3.  Collateral circulation in human heart.

Authors:  Aida Hasanović; Fuad Sisić; Faruk Dilberović; Fehim Ovcina
Journal:  Bosn J Basic Med Sci       Date:  2005-05       Impact factor: 3.363

4.  Vasoresponsiveness of collateral vessels in the rat hindlimb: influence of training.

Authors:  Patrick N Colleran; Zeyi Li; Hsiao T Yang; M Harold Laughlin; Ronald L Terjung
Journal:  J Physiol       Date:  2010-03-01       Impact factor: 5.182

Review 5.  Coronary microvascular adaptations distal to epicardial artery stenosis.

Authors:  Daphne Merkus; Judy Muller-Delp; Cristine L Heaps
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-05-07       Impact factor: 5.125

6.  The relation between endothelial dependent flow mediated dilation of the brachial artery and coronary collateral development - a cross sectional study.

Authors:  Aydan Ongun Ozdemir; Sadi Gulec; Nihal Uslu; Cansin Tulunay Kaya; Cagdas Ozdol; Sibel Turhan; Yusuf Atmaca; Timucin Altin; Cetin Erol
Journal:  Cardiovasc Ultrasound       Date:  2009-06-15       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.